InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

30
Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Stevens
5 Oct 2026
Chief Regulatory Officer
Sell
316
$4.39
$1.39K
Richard Marshak
5 Oct 2026
Chief Commercial Officer
Sell
325
$4.39
$1.43K
Bryan F. Cox
5 Oct 2026
Chief of Research
Sell
296
$4.39
$1.30K
Gary B. Gordon
15 May 2026
Director
Buy
10,000
$2.46
$24.60K
David Patience
15 May 2026
Chief Financial Officer
Buy
7,100
$2.43
$17.25K
Mary T Szela
15 May 2026
CEO and President
Buy
39,682
$2.59
$102.78K
Michael P Stansky
15 May 2026
Director
Buy indirect
200,000
$2.50
$500.00K
Michael P Stansky
15 May 2026
Director
Buy
410,000
$2.50
$1.03M
Mats Wahlstrom
15 May 2026
Director
Buy
60,000
$2.53
$151.80K
Richard Marshak
15 May 2026
Chief Commercial Officer
Sell
543
$2.67
$1.45K
Mary T Szela
17 Mar 2026
CEO and President
Sell
15,944
$3.85
$61.38K
Jennifer Stevens
16 Mar 2026
Chief Regulatory Officer
Sell
774
$4.12
$3.19K
Richard Marshak
16 Mar 2026
Chief Commercial Officer
Sell
419
$4.12
$1.73K
Bryan F. Cox
16 Mar 2026
Chief of Research
Sell
579
$4.12
$2.39K
Jodi Devlin
16 Mar 2026
Chief of Clinical Operations
Sell
273
$4.12
$1.12K
Jennifer Stevens
12 Mar 2026
Chief Regulatory Officer
Sell
1,552
$4.09
$6.35K
Richard Marshak
12 Mar 2026
Chief Commercial Officer
Sell
1,589
$4.09
$6.50K
Bryan F. Cox
12 Mar 2026
Chief of Research
Sell
1,467
$4.09
$6.00K
Jodi Devlin
12 Mar 2026
Chief of Clinical Operations
Sell
1,772
$4.09
$7.25K
Mary T Szela
11 Mar 2026
CEO and President
Sell
4,358
$4.13
$18.00K
Jennifer Stevens
11 Mar 2026
Chief Regulatory Officer
Sell
1,204
$4.13
$4.97K
Richard Marshak
11 Mar 2026
Chief Commercial Officer
Sell
1,449
$4.13
$5.98K
Bryan F. Cox
11 Mar 2026
Chief of Research
Sell
1,138
$4.13
$4.70K
Jodi Devlin
11 Mar 2026
Chief of Clinical Operations
Sell
1,162
$4.13
$4.80K
Michael P Stansky
23 Feb 2026
Director
Buy indirect
117,198
$4.10
$480.51K
Michael P Stansky
23 Feb 2026
Director
Buy
243,900
$4.10
$999.99K
Mary T Szela
23 Feb 2026
CEO and President
Buy
30,487
$4.10
$125.00K
William Valle
23 Feb 2026
Director
Buy
30,487
$4.10
$125.00K
Gary B. Gordon
23 Feb 2026
Director
Buy
9,756
$4.10
$40.00K
David Patience
23 Feb 2026
Chief Financial Officer
Buy
3,657
$4.10
$14.99K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 1,072,287
History held since 28 Dec 2020